Identification of the designer steroid Androsta-3,5-diene-7,17-dione in a dietary supplement.
A liquid chromatography-mass spectrometry (LC-MS) screen for known anabolic-androgenic steroids in a dietary supplement product marketed for "performance enhancement" detected an unknown compound having steroid-like spectral characteristics. The compound was isolated using high performance liquid chromatography with ultraviolet detection (HPLC-UV) coupled with an analytical scale fraction collector. After the compound was isolated, it was then characterized using gas chromatography with simultaneous Fourier Transform infrared detection and mass spectrometry (GC-FT-IR-MS), liquid chromatography-high resolution accurate mass-mass spectrometry (LC-HRAM-MS) and nuclear magnetic resonance (NMR). The steroid had an accurate mass of m/z 285.1847 (error-0.57 ppm) for the protonated species [M + H]+ , corresponding to a molecular formula of C19 H24 O2 . Based on the GC-FT-IR-MS data, NMR data, and accurate mass, the compound was identified as androsta-3,5-diene-7,17-dione. Although this is not the first reported identification of this designer steroid in a dietary supplement, the data provided adds information for identification of this compound not previously reported. This compound was subsequently detected in another dietary supplement product, which contained three additional active ingredients.
['Lorenz|Lisa M|LM|https://orcid.org/0000-0002-0493-720X', 'Toomey|Valerie M|VM|', 'Lanzarotta|Adam C|AC|', 'Flurer|Rick A|RA|', 'Falconer|Travis M|TM|https://orcid.org/0000-0002-9718-8972']
D000730:Androstadienes D002851:Chromatography, High Pressure Liquid D015198:Designer Drugs D019587:Dietary Supplements D008401:Gas Chromatography-Mass Spectrometry D009682:Magnetic Resonance Spectroscopy D017550:Spectroscopy, Fourier Transform Infrared D015813:Substance Abuse Detection
designer steroid LC-MS HPLC-UV GC-FT-IR-MS NMR